• No results found

Neonatal management and outcome in red cell alloimmunization Smits-Wintjens, V.E.H.J.

N/A
N/A
Protected

Academic year: 2021

Share "Neonatal management and outcome in red cell alloimmunization Smits-Wintjens, V.E.H.J."

Copied!
13
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Neonatal management and outcome in red cell alloimmunization

Smits-Wintjens, V.E.H.J.

Citation

Smits-Wintjens, V. E. H. J. (2012, February 15). Neonatal management and outcome in red cell alloimmunization. Retrieved from

https://hdl.handle.net/1887/18485

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/18485

Note: To cite this publication please use the final published version (if applicable).

(2)

List of abbreviations Authors and affiliations

Curriculum Vitae Publications

Dankwoord

(3)

162

(4)

List of abbreviations

AAP American Academy of Pediatrics BSID Bayley Scales of Infant Development CI Confidence interval

CP Cerebral palsy EPO Erythropoietin

ET(s) Exchange transfusion(s)

Hb Hemoglobulin

HDFN Hemolytic disease of the fetus/newborn HDN Hemolytic disease of the neonate/newborn IgG Immunoglobulin

IQR Interquartile range IUT(s) Intrauterine transfusion(s) IVIg Intravenous immunoglobulin

LIVIN Leiden’s IVIg trial in Rhesus disease of the Neonate LOTUS LOng-Term follow-up after intraUterine transfusionS LUMC Leiden University Medical Center

MDI Mental developmental index MND Minor neurological dysfunction NDI Neurodevelopmental impairment

OR Odds ratio

PT Phototherapy

RCT Randomized controlled trial

Rh Rhesus

Rh D Rhesus D

RHDN Rhesus hemolytic disease of the neonate/newborn SD Standard deviation

WISC Dutch version of Wechsler Intelligence Scale for Children

WPPSI Dutch version of Wechsler Preschool and Primary Scale of Intelligence

(5)

164

(6)

Authors and affiliations

From the Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden:

Vivianne Smits-Wintjens, Mirjam Rath, Sylke Steggerda, Arjan te Pas, Frans Walther, Enrico Lopriore

From the Division of Fetal Medicine, Department of Obstetrics, Leiden University Medical Center, Leiden:

Irene Lindenburg, Dick Oepkes, Inge van Kamp, Jan van Lith, Humphrey Kanhai

From the Department of Immuno-Hematology and Blood Transfusion, Leiden University Medical Center, Leiden:

Anneke Brand, Esther Verduin, Henk Schonewille, Ilias Doxiadis

From the Department of Biostatistics, Leiden University Medical Center, Leiden:

Erik van Zwet

From the Department of Medical Psychology, Leiden University Medical Center, Leiden:

Jeanine van Klink

From Sanquin Blood Supply Foundation, Amsterdam:

Christine Kramer

(7)

166

(8)

Curriculum Vitae

Vivianne Smits-Wintjens

Geboren op 17 februari 1972 te Maastricht

1984 - 1991 Gymnasium bèta, Sint Maartenscollege, Maastricht 1991 - 1998 Studie Geneeskunde, Rijksuniversiteit Groningen

1995 Wetenschapsstage afdeling Neonatologie, Landeskrankenhaus, Graz 1998 - 2000 AGNIO Kindergeneeskunde, Isala Klinieken, Zwolle

2000 - 2001 AGNIO Kinder-IC, Leids Universitair Medisch Centrum, Leiden 2001 - 2005 Opleiding Kindergeneeskunde,

Leids Universitair Medisch Centrum, Leiden (Prof. dr. J.M. Wit) Reinier de Graaf Gasthuis, Delft (dr. N. van der Lely)

2005 Chef de Clinique afdeling Kindergeneeskunde, Reinier de Graaf Gasthuis, Delft

2006 - 2009 Fellowship Neonatologie, Leids Universitair Medisch Centrum, Leiden (Prof. dr. F.J. Walther)

2006 - 2011 Promotieonderzoek (o.a. LIVIN studie), afdelingen Neonatologie en Verloskunde, Leids Universitair Medisch Centrum, Leiden

Vanaf 2009 Staflid Neonatologie, Leids Universitair Medisch Centrum, Leiden

(9)

168

(10)

Publications

1. Smits-Wintjens VEHJ, Rath MEA, Lindenburg ITM, Oepkes D, van Zwet EW, Walther FJ, Lopriore E. Cholestasis in neonates with red cell alloimmune hemolytic disease: inci- dence, risk factors and outcome.

Neonatology; In press

2. Lindenburg IT, Smits-Wintjens VE, van Klink JM, Verduin E, van Kamp IL, Walther FJ, Schonewille H, Doxiadis II, Kanhai HH, van Lith JM, van Zwet EW, Oepkes D, Brand A, Lopriore E; LOTUS study group. Long-term neurodevelopmental outcome after intrau- terine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.

Am J Obstet Gynecol 2011; Epub ahead of print.

3. Steggerda SJ, de Bruïne FT, Smits-Wintjens VE, Walther FJ, van Wezel-Meijler G. Ultrasound detection of posterior fossa abnormalities in full-term neonates.

Early Hum Dev 2011; Epub ahead of print.

4. Rath ME, Smits-Wintjens VE, Oepkes D, van Zwet EW, van Kamp IL, Brand A, Walther FJ, Lopriore E. Thrombocytopenia at birth in neonates with red cell alloimmune haemo- lytic disease.

Vox Sang 2011; Epub ahead of print.

5. Rath ME, Smits-Wintjens VE, Walther FJ, Lopriore E. Hematological morbidity and man- agement in neonates with hemolytic disease due to red cell alloimmunization.

Early Hum Dev 2011; 87(9):583-8.

6. Smits-Wintjens VE, Walther FJ, Rath ME, Lindenburg IT, te Pas AB, Kramer CM, Oepkes D, Brand A, Lopriore E. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial.

Pediatrics 2011; 127(4):680-6.

7. Rath ME, Smits-Wintjens VE, Lindenburg IT, Brand A, van Kamp IL, Oepkes D, Walther FJ, Lopriore E. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.

(11)

170

8. Verduin EP, Lindenburg IT, Smits-Wintjens VE, van Klink JM, Schonewille H, van Kamp IL, Oepkes D, Walther FJ, Kanhai HH, Doxiadis II, Lopriore E, Brand A. Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.

BMC Pregnancy Childbirth 2010; 10:77.

9. Van der Lugt NM, Smits-Wintjens VE, van Zwieten PH, Walther FJ.Short and long term outcome of neonatal hyperglycemia in very preterm infants: a retrospective follow-up study.

BMC Pediatr 2010;10:52.

10. Verheij GH, Te Pas AB, Witlox RS, Smits-Wintjens VE, Walther FJ, Lopriore E. Poor accuracy of methods currently used to determine umbilical catheter insertion length.

Int J Pediatr 2010;873167.

11. Rath ME, Smits-Wintjens VE, Lindenburg IT, Brand A, Oepkes D, Walther FJ, Lopriore E.

Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.

Vox Sang 2010;99(1):65-70.

12. Smits-Wintjens VEHJ, Steggerda SJ, Oepkes D, van Kamp IL, Kramer CM, Walther FJ, Lopriore E. Bacillus cereus cerebral abscesses in a term neonate with Rhesus haemolytic disease treated with exchange transfusion.

J Pediatr Inf Dis 2010; 5(3):277-280.

13. Verheij G, Smits-Wintjens V, Rozendaal L, Blom N, Walther F, Lopriore E. Cardiac arrhyth- mias associated with umbilical venous catheterisation in neonates.

BMJ Case Rep 2009; bcr04.2009.1778.

14 . Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn:

Postnatal management, associated morbidity and long-term outcome.

Semin Fetal Neonatal Med 2008 Aug;13(4):265-71.

15. Smits-Wintjens VE, Zwart P, Brand PL. Underlying cow’s milk protein intolerance in ex- cessively crying infants; desirable and undesirable effects of an elimination diet.

Ned Tijdschr Geneeskd 2000;144(48):2285-7.

(12)

Veel dank aan...

Mika en alle andere participerende kinderen en hun ouders

en iedereen die op een positieve manier heeft bijdragen om dit proefschrift tot iets moois te maken.

(13)

172

...sjoen op tied veerdig!

Referenties

GERELATEERDE DOCUMENTEN

In our center term neonates with RHDN are treated with transfusions of red blood cells when hemoglobin levels fall below 8.0 g/dL (5.0 mmol/L) or below 9.6 g/dL

We recorded the following obstetric and neonatal data: fetal hemoglobin (Hb) concentration and gestational age at first IUT, number of IUTs, gestational age at birth, birth weight,

Umbilical venous catheterization was required in this case because an ET was deemed necessary to reduce the elevated bilirubin levels and the risk of

(classified according to Bell’s criteria 20 ), proven sepsis (clinical and/or biochemical signs of infection with a positive blood culture), suspected sepsis (clinical

6,8-10 Data on the incidence and severity of cholestasis in neonates with red cell alloimmune hemolytic disease is scarce, and little is known about pathogenesis, risk

We recorded the following obstetric and neonatal data: type of red cell alloimmunization, number of IUTs, presence of fetal hydrops, fetal platelet count before each IUT, number of

The aim of this study was to evaluate the effect of this new guideline on the number of top-up transfusions and determine if neonates with hemolytic disease of the newborn

We recorded the following obstetric and neonatal data: fetal hemoglobin concentration at first IUT and number of IUTs, gestational age at birth, birth weight, hemoglobin level and